Lomaira is an 8 mg tablet formulation of the drug known generically as low-dose phentermine hydrochloride [1]. It is prescribed for the short-term management of obesity [1].
What is phentermine used for?
Phentermine is a stimulant that affects the central nervous system, and it works by suppressing appetite [2]. It is typically used in conjunction with diet and exercise for weight management [2]. Lomaira, at its 8 mg dose, is intended for individuals struggling to lose weight with standard dosages or who require more frequent dosing [1].
How does Lomaira compare to other phentermine formulations?
Lomaira's 8 mg tablet is designed for more frequent administration, with the possibility of taking it up to three times a day, before meals [1]. This differs from higher-dose phentermine formulations which are usually taken once daily [3]. The lower dose and potential for multiple daily administrations aim to provide a more tailored approach to appetite control for certain patients [1].
When does phentermine patent exclusivity end?
Information on specific patent expiry dates for phentermine formulations, including Lomaira, can be found on resources like DrugPatentWatch.com [4]. These patents can be complex, involving not only the active pharmaceutical ingredient but also specific formulations, methods of use, and manufacturing processes [5]. Patent challenges can also impact the timeline for generic competition [6].
Are there alternatives to phentermine for weight loss?
Several other prescription medications are available for weight management, including other appetite suppressants, fat absorption inhibitors, and medications that affect hormones involved in appetite regulation [7]. These alternatives may have different mechanisms of action, side effect profiles, and contraindications [7].
What are the risks and side effects of phentermine?
As a stimulant, phentermine can cause side effects such as increased heart rate, elevated blood pressure, dry mouth, insomnia, and nervousness [2]. It carries risks, particularly for individuals with pre-existing cardiovascular conditions, and is not suitable for everyone [2]. A healthcare provider assesses a patient's medical history to determine if phentermine is an appropriate and safe treatment option [2].
Sources:
1. https://www.lomaira.com/
2. https://www.drugs.com/phentermine.html
3. https://www.rxlist.com/lomaira-drug-side-effects-interactions-dosage.htm
4. https://drugpatentwatch.com/
5. https://www.drugbank.ca/drugs/PHEN001
6. https://www.natlawreview.com/article/drug-patent-litigation-trends-2023
7. https://www.mayoclinic.org/diseases-conditions/obesity/in-depth/weight-loss-drugs/art-20047744